L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients

Journal of Neural Transmission

Volumn 107, Issue 2, 2000, Pages 183-189

  Kuiper, M A ^a   Teerlink, T ^a   Visser, J J ^a   Bergmans, P L M ^a   Scheltens, P ^a   Wolters, E Ch ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Biopterin; Cerebrospinal fluid; L arginine; L citrulline; L glutamate; Multiple system atrophy; Nitrate; Nitric oxide; Parkinson's disease

Indexed keywords

AMINO ACID; ARGININE; CITRULLINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

EID: 0033977117     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050016     Document Type: Article

References (34)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed, revised. American Psychiatric Association, Washington
2. Barford PA, Blair JA, Eggar C, Hamon C, Morar C, Whitburn SB (1984) Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry 47: 736-738
3. Boje KM, Arora PK (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587: 250-256
4. Bredt DS, Hwang PM, Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768-770
5. Dawson TM, Dawson VL, Snyder SH (1992) A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 32: 297-311
6. Ferrarese C, Pecora N, Frigo M, Appolonio I, Frattola L (1993) Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol 33: 316-319
7. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281: 627-630
8. Hevel JM, Marletta MA (1992) Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activity. Biochemistry 31: 7160-7165
9. Hibbs JB, Taintor RR, Vavrin Z (1987a) Macrophage cytotoxicity: role for L-Arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476
10. Hibbs JB, Vavrin Z, Taintor RR (1987b) L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immuno 138: 550-565
11. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
12. Jiménez-Jiménez FJ, Molina JA, Vargas C, Gomez P, Navarro JA, Benito-León J, Ortí-Pareja M, Gasalla T, Cisneros E, Arenas J (1996) Neurotransmitter aminoacids in the cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 141: 39-44
13. Kuiper MA, Teerlink T, Bergmans PLM, Scheltens Ph, Van Pelt W, Wolters ECh (1993) CSF biopterin and neopterin levels in Alzheimer's disease and Parkinson's disease. In: Nicolini M, Zatta PF, Corain B (eds) Advances in biosciences, vol 87. Alzheimer's disease and related disorders 1992. Pergamon Press, Oxford, pp 97-103
14. Kuiper MA, Visser JJ, Bergmans PLM, Scheltens Ph, Wolters ECh (1994) Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and Multiple System Atrophy patients. J Neurol Sci 121: 46-49
15. Lakke JPWF, Teelken AW, vd Voet H, Wolthers BG (1986) Amino acid abnormalities in cerebrospinal fluid and blood serum of patients with Parkinson's disease, other heredodegenerative disorders and head injuries. Adv Neurol 45: 243-247
16. Lowe SL, Bowen DM, Francis PT, Neary D (1990) Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38: 571-577
17. Mally J, Szalai G, Stone TW (1997) Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 151: 159-162
18. McEntee WJ, Crook TH (1993) Glutamate: its role in learning, memeory, and the aging brain. Psychopharmacology 111: 391-401
19. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer' disease. Neurology 34: 939-944
21. Molina JA, Jiménez-Jiménez FJ, Navarro JA, Vargas C, Gomez P, Benito-León J, Ortí-Pareja M, Cisneros E, Arenas J (1996) Cerebrospinal fluid nitrate levels in patients with Parkinson's disease. Acta Neurol Scand 93: 123-126
22. Moncada S, Radomski MW, Palmer RMJ (1988) Endothelium derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37: 2495-2501
23. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
24. Nagatsu T, Yamaguchi T, Kato T, Sugimoto T, Matsuura S, Akino M, Nagatsu I, lizuka R, Narabayashi H (1981) Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay. Clin Chim Acta 109: 305-311
25. Pomara N, Singh R, Deptula D, Chou JC-Y, Schwartz MB, Le Witt P (1992) Glutamate and other CSF amino acids in Alzheimer's disease. Am J Psychiatry 149: 251-254
26. Quinn N (1989) Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry 52 [Suppl]: 78-89
27. Qureshi GA, Baig S, Bednar I, Södersten, Forsberg G, Siden A (1995) Increased cerebrospinal fluid concentrations of nitrite in Parkinson's disease. NeuroReport 6:1642-1644
28. Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9: 339-349
29. 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology 42: 556-561
30. Snyder SH, Bredt DS (1991) Nitric oxide as neuronal messenger. Trends Pharmacol Sci 12: 125-128
31. Teerlink T, Leeuwen van PAM, Houdijk A (1994) Plasma amino acids determined by liquid chromatography within 17 minutes. Clin Chem 40: 245-249
32. Toghi H, Abe T, Hashiguchi K, Takahasiv S, Nozaki Y, Kikuchi T (1991) A significant reduction of excitatory amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration. Neurosci Lett 126: 155-158
33. Toghi H, Abe T, Takahasi S, Kimura M (1992) A selective reduction of excitatory amino acids in cerebrospinal fluid of patients with Alzheimer type dementia compared with vascular dementia of the Binswanger type. Neurosci Lett 141: 5-8
34. 123I-IBZM Single Photon Emission Computed Tomography. Arch Neurol 50: 513-516